Impact statement
Peptide Therapeutics and Membrane Biology research group identifies novel disease biomarkers/targets and designs novel anticancer and antimicrobial therapeutic leads less likely to develop drug resistance, than traditional therapies. Our peptide-based drugs & diagnostic tools will result in better outcomes for cancer patients and for treatment of infectious diseases.